Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biohaven Pharmaceutical Holding Company Ltd (BHVN)

Biohaven Pharmaceutical Holding Company Ltd (BHVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biohaven Pharmaceutical Holding Company Ltd 215 CHURCH STREET NEW HAVEN CT 06510 USA

P: 203-404-0410

Description:

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,487,426
Shares Outstanding, K 62,041
Annual Sales, $ 63,630 K
Annual Net Income, $ -766,800 K
Last Quarter Sales, $ 35,110 K
Last Quarter Net Income, $ -217,740 K
60-Month Beta 1.01
% of Insider Shareholders 15.20%
% of Institutional Shareholders 90.01%
Float, K 52,611
% Float 84.80%

Growth:

1-Year Return 76.20%
3-Year Return 150.02%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.69 on 03/01/21
Next Earnings Date 05/06/21
Earnings Per Share ttm -11.83
EPS Growth vs. Prev Qtr -10.70%
EPS Growth vs. Prev Year -27.02%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

BHVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -7.26
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -115.07%
Profit Margin % -1,205.09
Net Margin % N/A
Debt/Equity N/A
Price/Sales 72.55
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -6.54
Interest Coverage -7.87
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar